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a  b  s  t  r  a  c  t
Hand,  foot,  and  mouth  disease  (HFMD)  mainly  caused  by  Enterovirus  71  (EV71)  and  coxsackievirus  A16
(CA16)  infections  which  presented  signiﬁcantly  different  clinical  manifestations.  Nevertheless,  the  fac-
tors  underlying  these  differences  remain  unclear.  Recently,  the  functions  of  microRNAs  (miRNAs)  in
pathogen-host  interactions  have  been  highlighted.  Here,  we  performed  comprehensive  miRNA  proﬁling
in  EV71-  and CA16-infected  human  bronchial  epithelial  (16HBE)  cells  at  multiple  time  points  using  high-
throughput  sequencing.  The  results  showed  that  154  known  and 47 novel  miRNAs  exhibited  remarkable
differences  in expression.  Of  these,  65  miRNAs,  including  58 known  and 7  novel  miRNAs,  presented
opposite  trends  in EV71-  and  CA16-infected  samples.  Subsequently,  we  mainly  focused  on  the  56 known
differentially  expressed  miRNAs  by further  screening  for targets  prediction.  GO  and  pathway  analysis
of  these  targets  demonstrated  that  18 biological  processes,  7  molecular  functions,  1  cellular  component
and  123  pathways  were  enriched.  Among  these  pathways,  Cadherin  signalling  pathway,  Wnt  signalling
pathway  and  angiogenesis  showed  signiﬁcant  alterations.  The  regulatory  networks  of  these  miRNAs
with  predicted  targets,  GOs,  pathways  and  transcription  factors  were  determined,  which  suggested  that
miRNAs  displayed  intricate  regulatory  mechanisms  during  the  infection  phase.  Consequently,  we specif-
ically  analysed  the hierarchical  GO  categories  of the  predicted  targets  involved  in  adhesion.  The  results
indicated  that  the  distinct  changes  induced  by EV71  and  CA16  infection  may  be  partly  linked  to  airway
epithelial  barrier  function.  Taken  together,  our data  provide  useful  insights  that help  elucidate  the  dif-
ferent  host-pathogen  interactions  following  EV71  and CA16  infection  and  might  offer novel  therapeutic
targets  for  these  infections.
©  2016  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Hand, foot and mouth disease (HFMD), a common viral illness
mong infants and children younger than 5 years old, has clinical
anifestations of fever, sore throat, general malaise and vesicular
ash on the hands and feet as well as exanthema on oral mucosa
nd tongue (Aswathyraj et al., 2016). HFMD is mostly caused by
oxsackievirus A16 (CA16) and enterovirus 71 (EV71) infection
Mao  et al., 2014; Solomon et al., 2010). Although HFMD is gen-
rally asymptomatic or presents with benign symptoms, it may
∗ Corresponding author at: Institute of Medical Biology, Chinese Academy of Med-
cal  Science and Peking Union Medical College. 935 Jiaoling Road, Kunming, Yunnan,
hina.
E-mail address: liqihan@imbcams.com.cn (Q. Li).
ttp://dx.doi.org/10.1016/j.virusres.2016.11.024
168-1702/© 2016 The Authors. Published by Elsevier B.V. This is an open access article 
/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
also lead to severe neurological complications, such as acute ﬂaccid
paralysis, encephalitis, encephalomyelitis and fulminant neuro-
genic pulmonary oedema, which are associated with high mortality
(Muehlenbachs et al., 2015). Therefore, HFMD has emerged as a
major public health problem, particularly in the Asia-Paciﬁc region
(Koh et al., 2016). In the past several years, large outbreaks of HFMD
have been reported, and these were caused by the co-circulation or
alternative cycling of EV71 and CA16 in China (Liu et al., 2014).
Although both EV71 and CA16 belong to the human enterovirus
A (HEV-A) species of the Picornaviridae family, the clinical man-
ifestations and pathogenesis of HFMD caused by the two  viruses
have some discrepancies (Li et al., 2011; Puenpa et al., 2011). Gen-
erally, EV71 infection easily progresses into serious central nervous
system (CNS) complications and even leads to death, while CA16
infection often results in mild and self-limited clinical symptoms
(Mao  et al., 2014; Solomon et al., 2010). In consideration of the con-
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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picuous morbidity and mortality induced by EV71 infection, the
evelopment of a HFMD vaccine has mainly targeted EV71 in recent
ears. Also, an inactivated EV71 vaccine has successfully entered
nto the market, but this vaccine does not provide effective pro-
ection against infections with other enteroviruses, such as CA16
Li et al., 2014a; Li et al., 2014b). Additionally, accumulating evi-
ence has revealed that a small number of patients infected with
A16 are also capable of developing potentially severe neurologi-
al complications, such as aseptic meningitis, encephalitis and even
atal neurogenic pulmonary oedema, which can elicit serious injury
r even death (Mao  et al., 2014). Thus, on-going explorations into
he molecular bases of HFMD pathogenesis and progression caused
y EV71 and CA16 infection may  reveal novel approaches for the
evelopment of a CA16 monovalent vaccine or an EV71-CA16 biva-
ent vaccine, improving the prophylaxis and treatment of HFMD
nd potentially even eradicating the disease.
microRNAs (miRNAs) are short (∼21 nucleotides long), endoge-
ous, non-coding RNAs (Krol et al., 2010; Treiber et al., 2012). Their
iscovery has greatly expanded our understanding of the cellular
echanisms that regulate gene expression by the sequence-
elective targeting of messenger RNAs (mRNAs), leading to their
leavage or reduction in the translational efﬁciency (Ha and Kim,
014). Furthermore, miRNA biogenesis has unique tissue-speciﬁc,
evelopmental stage-speciﬁc and disease-speciﬁc patterns (Winter
t al., 2009). Recently, an increasing number of studies have
emonstrated that miRNAs govern a wide variety of biological
rocesses, such as the establishment and maintenance of the cell
ate of immune cells, the regulation of innate immune and adap-
ive immune responses, the modulation of tissue differentiation,
ellular apoptosis, signal transduction and organ development
Lee et al., 2014; O’Connell et al., 2010). Moreover, miRNA dys-
egulation is associated with many diseases, including cancer,
euro-developmental disorders, cardiovascular disorders and most
nﬂammatory diseases (Busch et al., 2016; Mehta and Baltimore,
016; Piva et al., 2013). As such, miRNAs are increasingly rec-
gnized as biomarkers for disease diagnosis as well as novel
herapeutic targets (Busch et al., 2016; Louten et al., 2015). As
nderstanding of miRNAs has increased in recent decades, it has
een revealed that miRNAs of cellular origin are likely involved in
ellular defences against viral infections, whereas miRNAs of viral
rigin might confer multiple defences to enhance viral replication
nd survival in host cells (Cullen, 2006; Skalsky and Cullen, 2010;
ullivan and Ganem, 2005). Therefore, research into cellular and
irus-encoded miRNA function will not only augment our under-
tanding of host-virus interplay but also reveal new approaches for
he treatment of virus-induced diseases.
Currently, accumulating evidence has indicated that EV71 infec-
ion can elicit ectopic miRNA expression, resulting in cellular
poptosis, which is an important cellular defence mechanism, par-
icularly in the early phase of pathogen infection (Ho et al., 2016;
u et al., 2015). Moreover, many studies have clearly shown that
he miRNAs that are induced by EV71 infection can directly tar-
et host genes, leading to cellular or tissue malfunctions and viral
athogenesis (Lei et al., 2016; Wu  et al., 2015). Hence, based on
he above studies and the different clinical symptoms that are pro-
uced by EV71 and CA16 infection, we hypothesized that the host
iRNAs induced by CA16 infection might be distinct from those
nduced by EV71 infection. Alternatively, EV71 and CA16 infection
oth triggered some of the same miRNAs, but their expression lev-
ls may  present opposite between the two viruses. Additionally,
ur previous study demonstrated that EV71 infection presented
ore typical pathologic changes in the respiratory tract than inhe alimentary tract (unpublished results). However, it has become
ncreasingly clear that airway epithelial cells are not only central
articipants in defending against foreign pathogens by producing
ozens of antimicrobial molecules but also regulate both innate 228 (2017) 90–101 91
and adaptive immunity through recruiting immune system cells,
including dendritic cells (DCs), T cells and B cells (Brune et al., 2015;
Kato and Schleimer, 2007). Moreover, our previous work conﬁrmed
that EV71 and CA16 can be captured by different subsets of DCs
in airway epithelial cells in EV71 and CA16 airway-infected infant
rhesus monkeys (unpublished results). Therefore, we hypothe-
sized that differences generated in the respiratory tract following
infection with these two viruses could lead to variations in the
immune responses to or pathogenesis induced by the viruses.
Subsequently, high-throughput sequencing was  used to detect dif-
ferences in human bronchial epithelial (16HBE) cells, a pivotal
target of enterovirus infection within the respiratory tract, follow-
ing EV71 or CA16 infection.
2. Materials and methods
2.1. Cell culture and virus infection
16HBE cells purchased from the Jennino Biological Technology
were maintained in RPMI 1640 (Gibco, USA) supplemented with
L-glutamine, penicillin, streptomycin and 10% fetal bovine serum
(FBS, Gibco, USA) at 37 ◦C in a 5% CO2 containing incubator. For
in vitro virus infection, approximately 1 × 105 16HBE cells per well
were plated in 6-well plates and incubated overnight at 37 ◦C under
5% CO2. The 16HBE cells grown to 80% conﬂuence and infected with
EV71 (sub-genotype C4, GenBank: EU812515.1) or CA16-G20 strain
(sub-genotype B, GenBank: JN590244.1), which were isolated from
an epidemic in Fuyang, China in 2008 and from an HFMD patient
in Guangxi, China in 2010, respectively. The cells were infected at a
multiplicity of infection (MOI) of 10. The cells were harvested at 0,
6 and 12 h post infection (hpi). Cells infected with EV71 and CA16
for 0 hpi were used as controls. Simultaneously, we  deﬁned the
following experimental groups: EV71–0 h, EV71–6 h, EV71–12 h,
CA16–0 h, CA16–6 h and CA16–12 h. Additionally, the EV71–0 h and
CA16–0 h were used for normalization (the normalization value
was set to 1), and these two  groups were designated the Con. Each
group was evaluated in triplicate and pooled separately for subse-
quent total RNA extraction.
2.2. RNA isolation and quality control
Samples from the above groups were sent to the National Engi-
neering Center for Biochips in Shanghai. miRNA was extracted from
each group of cells using a mirVanaTM miRNA Isolation Kit (Ambion,
USA) according to the manufacturer’s instructions. RNA was further
puriﬁed using a miRNeasy Mini kit (Qiagen, Germany) following
the manufacturer’s protocol. RNA concentration and RNA integrity
were assessed by capillary electrophoresis on an Agilent 2100 Bio-
analyzer (Agilent Technologies, USA); only samples with an RNA
integrity number (RIN) > 7 were used for miRNA proﬁle analysis.
2.3. Small RNA library preparation, high-throughput sequencing
and miRNA-seq data analysis
High-throughput sequencing is a useful tool for transcriptome
studies, as it can capture almost all expressed transcripts, including
known and novel transcripts. Additionally, it has lower background
noise and higher sensitivity than microarrays (Chen et al., 2011).
Sequencing libraries of the above samples were generated using
a standard TruSeq Small RNA sample preparation kit (Illumina,
USA) according to manufacturer recommendations and then pre-
pared for Illumina sequencing. Low-quality sequences, namely,
those with undetermined nucleotides (Ns), a quality score (Q-score)
less than 10, or reads shorter than 18 nt, were ﬁltered from the
libraries. The adapter sequences were also removed. Clean reads
for small RNAs (sRNAs) were acquired and mapped using Rfam
9 search
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http://rfam.janelia.org/) and piRNA (http://pirnabank.ibab.ac.in/)
o remove non-coding RNAs (e.g., rRNA, tRNA, snoRNA, or snRNA)
nd repetitive RNAs. After the sRNAs were ﬁltered with the above-
entioned processes and excluded, the remaining short reads were
apped to the known miRNA precursors, and the mature miR-
As were deposited in miRBase 19.0 (available online: http://
ww.mirbase.org/). Unmappable sequences were used to predict
otentially novel candidate miRNAs with the Mfold RNA folding
rediction web server (available online: http://mfold.rna.albany.
du/). Finally, 18–35 nt lengths of known and novel miRNAs were
elected for further analysis. The sequencing data were deposited in
he National Center for Biotechnology Information’s Gene Expres-
ion Omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo/) under
ccession number GSE85829.
.4. Data analysis
.4.1. Principal component analysis (PCA)
Clean data were obtained from the pre-processed miRNAs-seq
ata and then submitted to PCA to determine similarities and dis-
riminations among the groups.
.4.2. Differential expression analysis of miRNA sequences
To compare differential miRNA expression among the above-
escribed groups, miRNA frequency was normalized to the number
f transcripts per million clean tags (TPM). Subsequently, a fold
hange ≥ 2 indicated that the miRNAs in the EV71- and CA16-
nfected samples were up-regulated, while a fold change ≤ 0.5
ndicated that the miRNAs in the EV71- and CA16-infected samples
ere down-regulated. A P-value < 0.05 was selected as the cut-off
riterion.
.4.3. Clustering analysis
Hierarchical clustering, a method of non-monitoring cluster
nalysis, was used to achieve the clustering of the different miR-
As and groups of samples, enabling detection of the differential
xpression patterns of the miRNAs in the different groups. This was
ccomplished using average linkage clustering with Euclidean dis-
ances, treating the samples independently of each other, with the
plots heatmap.2 function of the R program. The normalized data
ere transformed to a log 2 scale for visualization purposes.
.4.4. Trend analysis
Log standardization of the differentially expressed miRNAs was
erformed to facilitate trend analysis of the miRNA expression
hanges in the different groups.
.4.5. Target prediction and functional enrichment of
ifferentially expressed miRNAs
Target genes of the differentially expressed miRNAs isolated by
rend analysis were predicted using the TargetScan (Lewis et al.,
003) and miRDB prediction programs (Wong and Wang, 2015). We
eﬁned putative targets by using the top 200 genes in TargetScan
nd a target score ≥ 80 in miRDB. To increase the reliability of the
esults, only target genes identiﬁed by both databases were consid-
red to be predicted target genes for the differentially expressed
iRNAs. Signiﬁcantly enriched GO categories were determined
ased on the false discovery rate (FDR ≤ 0.05). The FDR was cal-
ulated based on the Benjamini–Hochberg method and evaluated
sing default parameters to adjust the p-values. In addition, the
redicted miRNA target genes were analysed in terms of Kyoto
ncyclopedia of Genes and Genomes (KEGG) pathways using the
ANTHER Classiﬁcation System. 228 (2017) 90–101
2.4.6. Construction of regulatory networks
We constructed four regulatory networks: one containing tran-
scription factors (TFs) and miRNAs, one containing miRNAs and
target genes, one containing miRNAs and GO-biological processes,
and one containing miRNAs and pathways. A complex regulatory
network was  generated by computational methods and aimed to
reveal the crucial functions of the included miRNAs. Ensembl online
tools were employed to predict the TFs of the miRNAs. Furthermore,
to avoid false positives, a relative score of ≥ 0.99 was  chosen to
identify potential TFs. Three other regulatory networks were con-
structed to reveal the roles of the miRNAs based on interactions
between selected differentially expressed miRNAs and their tar-
get genes, interactions between the target genes and GO-biological
processes, and interactions between the target genes and path-
ways.
2.4.7. Hierarchical GO category analysis of deregulated
miRNA-associated target genes with key GO-biological process
categories
GO category trees were hierarchically created using the Gene
Ontology Enrichment Analysis Software Toolkit (GOEAST) to fur-
ther elucidate the critical functions of the deregulated miRNAs
during EV71 and CA16 infection.
2.5. miRNA and miRNA target quantiﬁcation by quantitative
RT-PCR (qRT-PCR) in the validation set
To validate the sequencing data, we randomly choose 8 differ-
entially expressed miRNAs, including 7 known miRNAs and 1 novel
miRNA, for qRT-PCR analysis using a Mir-X miRNA qRT-PCR SYBR
Kit (Clontech, USA). A total of 2 g of RNA was  ﬁrst polyadenylated
with polyA polymerase and then reverse-transcribed into cDNA
with a poly(T) adapter primer under the following reaction con-
ditions: 60 min  at 37 ◦C, 5 min  at 85 ◦C and maintenance at 4 ◦C.
After this was completed, 90 l ddH2O was  added to the cDNA for
miRNA quantiﬁcation. Finally, the cDNA was  ampliﬁed and quanti-
ﬁed using SYBR Advantage Premix, ROX Dye, nuclease-free water,
mRQ  3′ Primer and miRNA-speciﬁc 5′ primers on a 7500 Fast Real-
time PCR system (Applied Biosystems, USA) in accordance with the
manufacturer’s instructions. The ampliﬁcation reactions were all
carried out at 95 ◦C for 10 s, followed by 40 cycles of 95 ◦C for 10 s
and 60 ◦C for 40 s and then dissociation at 95 ◦C for 60 s, 55 ◦C for
30 s and 95 ◦C for 30 s. U6 snRNA was  served as an internal control,
and the 2−Ct method was  used to evaluate relative expression.
The experiment was performed using three independent biological
replicates. All miRNA-speciﬁc 5′ primers used in the qPCR experi-
ments are listed in Table S1.
Based on analysis of the predicted targets of the differentially
expressed miRNAs, we  randomly selected 20 targets for an indirect
corroboration of miRNA expression by qRT-PCR using a 7500 Fast
Real-time PCR system (Applied Biosystems, USA). Total cellular RNA
was isolated with TRIzol Reagent as recommended by the man-
ufacturer (TIANGEN, China). Reverse transcription and PCR were
performed using a One Step SYBR
®
PrimeScriptTM PLUS RT-PCR Kit
(TAKARA, Japan) following the manufacturer’s recommendations.
The qRT-PCR cycling conditions were 1 cycle at 42 ◦C for 5 min  and
1 cycle at 95 ◦C for 10 s, followed by a two-step PCR procedure con-
sisting of 5 s at 95 ◦C and 34 s at 60 ◦C for 40 cycles. -actin mRNA
was used as an endogenous control for data normalization. All gene
primers are listed in Table S2. The relative amount of expressed
mRNA was  also calculated by the 2−Ct method, and the experi-
ment was performed in technical triplicate.
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Table  1
Overview of miRNA-seq data processing of all samples.
Samples Raw reads Clean reads Adapter-trimmed reads
(length > = 18nt)
Reads aligned to known Homo sapiens
pre-miRNA in miRBase 19
EV71-0h 26,524,581 26,085,971 23,344,423 470,119
EV71-6h 23,917,420 23,594,094 21,513,316 727,081
EV71-12h 25,113,444 24,916,349 24,087,092 785,630
CA16-0h 22,778,666 22,626,697 21,930,664 523,108
CA16-6h 23,781,314 23,550,267 22,860,825 657,904
CA16-12h 18,535,354 18,212,558 16,088,596 468,647
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tndicated from left to right are the numbers of reads that raw sequencing data, pass
dapter  ﬁltering and length ﬁltering (adapter-trimmed reads ≥ 18nt), and the numb
erfect matches, respectively.
.6. Statistical analysis
For the sequencing data, the raw reads obtained from each
ibrary were normalized to TPM. For qRT-PCR, the data are
xpressed as the mean ± standard error means (SEM). Statistical
nalysis was performed using SPSS 18.0 (IBM SPSS, USA). P < 0.05
as considered statistically signiﬁcant for all analysis.
. Results
.1. Overview of miRNA sequencing data in 16HBE cells infected
ith EV71 and CA16
To evaluate the effects of EV71 and CA16 infection on 16HBE
iRNA expression, we carried out high-throughput small RNA
equencing using an Illumina platform and constructed 6 small
NA libraries. The details of the small RNA sequencing data gen-
ration for the 6 libraries and the subsequent analysis are shown
n Table 1. Different types of sRNAs, including miRNA, miscella-
eous RNA (misc RNA), ribosomal RNA (rRNA), small nucleolar RNA
snoRNA), small nuclear RNA (snRNA) and others, were identiﬁed
n the samples (see Fig. S1 in the online version at DOI: http://
x.doi.org/10.1016/j.virusres.2016.11.024). The read classiﬁcation
ndicated that miRNAs presented dynamic changes in both the
V71- and CA16-infected samples, with the abundance of miRNAs
n each sample being 22 nt in size. Thereafter, the discrete degree
f each sample group was examined using PCA (Fig. 1a). The results
evealed the distribution and clustering of the individual group
amples. The Con group and infected groups formed a tight separate
luster, whereas the EV71-infected groups and the CA16-infected
roups were grouped closely together, respectively. Interestingly,
he CA16–6 h group was closely grouped with the EV71-infected
roups. These results indicate that there was  a notable dispar-
ty between the EV71-infected groups and the CA16–12 h group,
hereas similarity existed between the EV71-infected groups and
he CA16–6 h group.
.2. Differential miRNA expression patterns in the EV71- and
A16-infected groups
To investigate the changes of miRNA expression proﬁles in the
6HBE cells during EV71 and CA16 infection, global cellular miRNA
xpression patterns following infection were compared with those
f the controls. In this study, only those differentially expressed
iRNAs with a P value < 0.05 and a fold change ≥ 2 or ≤ 0.5 are
escribed. The results showed that, compared with the EV71–0 h
roup, there were 14 up-regulated and 45 down-regulated known
iRNAs and 112 up-regulated and 35 down-regulated novel miR-
As in the EV71–6 h group, as well as 19 up-regulated and
5 down-regulated known miRNAs and 33 up-regulated and 50
own-regulated novel miRNAs in the EV71–12 h group. Moreover,
here were 16 up-regulated and 41 down-regulated known miRNAsality ﬁltering (clean reads), the numbers of reads that passed both quality ﬁltering,
eads that could be aligned to known Homo sapiens pre-miRNA in miRBase 19 with
and 61 up-regulated and 342 down-regulated novel miRNAs in the
CA16–6 h group, as well as 36 up-regulated and 42 down-regulated
known miRNAs and 37 up-regulated and 34 down-regulated novel
miRNAs in the CA16–12 h group relative to the CA16–0 h group
(Table S3).
Subsequently, the data for all the differentially expressed miR-
NAs were also graphed into a Venn diagram (Fig. 1b and d).
Common and distinct differentially expressed known and novel
microRNAs in response to EV71 and CA16 infection across all
time points were revealed. Subsequently, 154 known and 47
novel differentially expressed miRNAs were submitted to unsu-
pervised hierarchical clustering to construct two heat maps
based on the differential expression patterns with log 2 values
(infected/control) and fold changes (Fig. 1c and d). A positive log 2
value indicated up-regulation, and a negative log 2 value indicated
down-regulation. It is noteworthy that although 228 novel differ-
entially expressed miRNAs were identiﬁed across the samples, only
47 novel differentially expressed miRNAs were utilized in cluster
analysis, while the other 181 novel differentially expressed miR-
NAs were excluded. This was mainly due to a lack of expression of
some of these 181 miRNAs in at least one group. In both the known
and novel miRNA expression patterns, we  found that the patterns
induced by EV71 differed from those induced by CA16 at 6 hpi and
12 hpi. In addition, the miRNA expression patterns induced by EV71
at 6 hpi also differed from those induced by EV71 at 12 hpi, and the
same was  true for CA16. Therefore, these results elucidated that
known and novel miRNA expression patterns following infection
with EV71 and CA16 are strain- and time-speciﬁc.
Ultimately, the high-throughput dataset results were validated
by performing qRT-PCR for 8 randomly selected signiﬁcantly
differentially expressed miRNAs, namely, miR-378c, miR-451a,
miR-629-3p, miR-1287-5p, miR-3182, miR-4485-5p, miR-3651
and a novel miRNA (AGACGAGGGCTCCATAGCTC). The results were
in accordance with the high-throughput dataset (see Fig. S2 in the
online version at DOI: http://dx.doi.org/10.1016/j.virusres.2016.11.
024).
3.3. Trend analysis of the differentially expressed miRNAs
Trend analysis of miRNA expression dynamics was used to pro-
ﬁle the differentially expressed miRNAs and to identify the most
probable set of clusters generated in the time series. As a result,
we observed that 58 known and 7 novel differentially expressed
miRNAs were the most signiﬁcant miRNAs because their expres-
sion levels presented an opposite relationship over time following
EV71 and CA16 infection, which indirectly indicates that the differ-
ent manifestations that result from EV71 and CA16 infection may
be closely linked to these differentially expressed miRNAs (Fig. 2a
and b). In addition, the predicted structures of 7 novel differentially
expressed miRNAs are displayed in Fig. 2c. For each differen-
tially expressed miRNA, if the two  ratios (EV71–6 h/CA16–6 h and
EV71–12 h/CA16–12 h) fell between 0.5 and 2, the miRNA was  elim-
94 Y. Hu et al. / Virus Research 228 (2017) 90–101
Fig. 1. Overview of all miRNAs. (a) Principal component analysis (PCA) showing the distribution and clustering of the individual sample groups. Each spot represents a
single  array. It exhibits a clear separation between Con group and infected groups. (b) Venn diagram representing Known differentially expressed miRNAs. (c) Time- and
strain-speciﬁc regulation of differential miRNAs during EV71 and CA16 infections. The columns correspond to expression patterns of differentially expressed miRNAs during
the  EV71 and CA16 infections relative to Con samples at 6 hpi and 12 hpi. Signiﬁcance was  determined using a fold-change threshold of at least 2 and a P value cutoff
of  0.05. The intensity of the miRNA expression is indicated in green (lower level of expression) and red (higher level of expression). Dendrograms between samples and
between miRNAs are depicted, where the closest branches of the tree represents samples/miRNAs with the most similar expression pattern. (d) Novel differentially expressed
miRNAs. The names of these miRNAs are given in boxes. (e) Venn diagram representing novel signiﬁcant differentially expressed miRNAs in all samples. Colors indicate the
log2  fold changes with a ratio of EV71/CA16-infected sample versus control according to the TPM. The red color represents up-regulation, while the blue color indicates
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eown-regulation. (For interpretation of the references to colour in this ﬁgure legen
nated, leaving a total of 56 known differentially expressed miRNAs
or further analysis (Table 2).
.4. Prediction and annotation of miRNA putative target genes
To gain insight into the possible regulatory roles of the 56
nown differentially expressed miRNAs during EV71 and CA16
nfection, we used the TargetScan and miRDB programs to predict
he potential targets of these differentially expressed miRNAs. It
as found that 7417 genes were predicated to be potential tar-
ets with TargetScan, whereas 4444 genes were predicated to be
otential targets with miRDB. We  then looked for intersections of
hese genes for subsequent GO and pathway analysis. Predicted
arget functions were classiﬁed into biological process, molecu-
ar function, and cellular component by GO enrichment analysis
ased on a cut-off value of a 5% error rate (P < 0.05, determined
y t-test with Benjamini–Hochberg multiple testing correction).
he biological processes for the miRNA targets included biological
dhesion, biological regulation, cell adhesion, cell communica-
ion, cell-cell adhesion, cellular process, developmental process,
ctoderm development, nervous system development, regulationreader is referred to the web  version of this article.)
of biological process, regulation of catalytic activity, regulation
of molecular function, regulation of nucleobase-containing com-
pound metabolic process, regulation of transcription from RNA
polymerase II promoter, sensory perception of chemical stimu-
lus, system development, transcription from RNA polymerase II
promoter and transcription, DNA-dependent (Fig. 3a). The molec-
ular functions of the predicted miRNA targets included DNA
binding, binding, calcium ion binding, enzyme regulator activity,
nucleic acid binding transcription factor activity, protein binding
and sequence-speciﬁc DNA binding transcription factor activity
(Fig. 3b). Additionally, the actin cytoskeleton was a unique cellular
component of the miRNA targets (Fig. 3c). Afterwards, the pre-
dicted targets genes were subjected to KEGG pathway enrichment
analysis using the PANTHER Classiﬁcation System. As illustrated
in Fig. 4, 123 pathways were identiﬁed, suggesting that these
signalling pathways are regulated by the differentially expressed
miRNAs during virus infection. Furthermore, among the 123 path-
ways, there were 3 key pathways, namely, the Cadherin signalling
pathway, the Wnt  signalling pathway and angiogenesis, which had
signiﬁcant differences when using Bonferroni correction for multi-
ple testing (P values of 0.05).
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Fig. 2. Trend analysis of differentially expressed miRNAs in response to EV71 and CA16 infection over time. (a) The known differentially expressed miRNAs that showed
opposite expression patterns during the progression of EV71 and CA16 infection are given in boxes. (b) The boxes display the miRNA sequences of novel differentially
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.5. miRNA-gene, miRNA-GO, miRNA-pathway and TF-miRNA
egulation network construction
Building miRNA regulatory networks is very important for
igh-throughput analysis of interactions among miRNAs and genes,
Os, and pathways. First, to further conﬁrm the key target genes,
e looked for intersections of related genes in our GO and path-
ay analysis results. A total of 279 target genes were identiﬁed
nd listed in Fig. S3 in the online version at DOI: http://dx.doi.
rg/10.1016/j.virusres.2016.11.024. Next, 56 known differentially
xpressed miRNAs, 17 GOs involved in biological processes and
2 pathways were identiﬁed by reﬁning the correlations among
he 279 target genes and the miRNAs, GOs, and pathways. Conse-
uently, a miRNA-gene network was built based on interactions
etween miRNAs and genes (Fig. 5a). A miRNA-GO network was
stablished on the basis of relationships among signiﬁcant GOs
nd genes and relationships among miRNAs and genes (Fig. 5b).
 miRNA-pathway network was constructed in accordance with
elationships among signiﬁcant pathways and genes and relation-
hips among miRNAs and genes (Fig. 5c). miRNAs not only mediate
peciﬁc target gene products via hybridization to mRNA but are
lso regulated by TFs. Therefore, we performed TF-miRNA net-
ork analysis to study the relationships that existed among the
otentially predicted TFs and the 56 known differentially expressed
iRNAs (Fig. 5d). These regulatory networks demonstrated that the
ifferentially expressed miRNAs might play an important role in
athogenesis following EV71 and CA16 infection.
.6. Hierarchical GO category analysis and detection of target
enes involved in key biological processesIn this part, we speciﬁcally looked into the hierarchical GO cat-
gories of the deregulated miRNA-associated target genes and the
ey biological processes. 16HBE cells are airway epithelial barriern. (c) The location and putative folding structure of these opposed expressed novel
ctures obtained using Mfold. (For interpretation of the references to colour in this
cells and play an important role in airway defence, which is main-
tained through cell adhesion (Tam et al., 2011). Hence, we focused
on GOs related to adhesion and identiﬁed 3 GO terms, namely,
biological adhesion, cell adhesion and cell-cell adhesion in the bio-
logical process categories of the GO analysis. In total, 47 target
genes were identiﬁed among these 3 GO terms, and their corre-
sponding 24 known differentially expressed miRNAs are listed in
Table S4. Of these 24 miRNAs, 17 miRNAs were overexpressed and
7 miRNAs were reduced in the EV71 samples, while 17 miRNAs
were decreased and 7 miRNAs were increased in the CA16 sam-
ples. These target genes were then submitted to hierarchical GO
category analysis. In Fig. 6, the white circles represent the miRNAs
of no signiﬁcance and the yellow circles represent the miRNAs that
were signiﬁcantly overrepresented in the 21 biological processes
(P value < 0.05).
Eventually, we randomly selected 12 of the 47 target genes
for further analysis to conﬁrm the miRNA sequencing data. The
expression levels of the miRNAs and their targets generally pre-
sented opposite interactions based on the regulatory mechanisms
of the miRNAs. Except for LEF1 and NTNG1, the expression levels of
the other genes were inversely correlated with miRNA expression
(see Fig. S4 in the online version at DOI: http://dx.doi.org/10.1016/
j.virusres.2016.11.024).
4. Discussion
EV71 and CA16 have still been recognized as a major etio-
logical agent responsible for HFMD epidemics, which seriously
inﬂicts children worldwide (Koh et al., 2016). The development
of an inactivated EV71 vaccine has substantially improved the
health of children both in China and worldwide. However, this
vaccine fails to elicit protection against CA16 infection (Li et al.,
2014a; Li et al., 2014b). Thus, further investigations identifying
the factors that cause the different manifestations of EV17 and
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Table 2
Oppositely expressed miRNAs during the course of EV71 and CA16 infection.
miRNAs EV71–6 h (FC) CA16-6 h (FC) Ratio (EV71-6 h/CA16-6 h) EV71-12 h (FC) CA16-12 h (FC) Ratio (EV71-12 h/CA16-12 h)
miR-1268a 1.551802 0.397556 3.903349 0.239359 1.302244 0.183805
miR-190a-5p 2.198386 0.567938 3.870821 0.598397 0.956751 0.625448
miR-218-5p 0.969876 0.681525 1.423096 0.489598 0.903598 0.541832
miR-3196 0.711242 0.198778 3.57807 0.448798 1.209226 0.371145
miR-34c-5p 1.010288 0.366975 2.753013 0.411398 1.202071 0.342241
miR-3661 2.198386 0.883459 2.488385 1.077115 1.612302 0.668061
miR-4634 0.52133 0.32907 1.584252 0.454803 1.041951 0.436492
miR-615-5p 0.287371 0.099389 2.89137 0.132977 0.418578 0.317688
miR-7705 1.755014 1.490837 1.177201 1.453251 2.092892 0.694375
let-7i-3p 0.646584 1.060151 0.609898 0.769368 2.976557 0.258476
miR-1246 0.577015 0.564645 1.021907 0.647633 2.507426 0.258286
miR-1275 0.618472 0.864253 0.715614 0.182121 1.74711 0.104241
miR-134-5p 0.775901 1.590226 0.487919 0.359038 3.906732 0.091903
miR-135b-5p 1.697283 2.120301 0.800492 1.421194 3.348627 0.424411
miR-3141 0.727407 0.695724 1.04554 0.710597 2.790523 0.254647
miR-3182 0.97309 1.684882 0.577542 0.377121 5.244411 0.071909
miR-3195 0.2176 0.346588 0.627837 0.12083 5.552424 0.021762
miR-3613-5p 1.939752 3.180452 0.609898 0.598397 5.581045 0.10722
miR-3656 0.683085 1.209955 0.564554 0.757648 6.503131 0.116505
miR-3677-3p 0.161646 1.192669 0.135533 0.0748 3.348627 0.022337
miR-378a-5p 0.579696 0.773026 0.749905 0.980134 2.418453 0.405273
miR-3960 1.293168 1.169284 1.105949 0.957436 2.298077 0.416625
miR-4488 0.683887 0.841884 0.812329 0.448798 3.873902 0.115852
miR-4492 0.44592 0.270038 1.651321 0.254491 2.527266 0.100698
miR-4497 0.146951 0.280628 0.52365 0.163199 2.363737 0.069043
miR-4508 0.303397 0.164208 1.847638 0.308405 2.135356 0.144428
miR-4516 0.880349 1.073403 0.820148 0.94823 6.306581 0.150356
miR-4792 0.052235 0.397556 0.131391 0.132977 3.348627 0.039711
miR-5701 0.905218 0.905218 1 1.316474 5.022941 0.262092
miR-5787 0.952942 0.696479 1.368228 0.936065 2.040261 0.458797
miR-6087 0.679484 0.458719 1.481264 0.421302 2.071426 0.203387
miR-769-3p 0.727407 2.120301 0.343068 0.598397 2.976557 0.201037
miR-7704 0.383161 0.274946 1.393588 0.332443 3.404264 0.097655
miR-7976 0.646584 1.590226 0.406599 0.598397 3.348627 0.178699
miR-1226-5p 1.293168 0.397556 3.252791 0.470119 0.065389 7.189628
miR-1276 2.586336 1.192669 2.168527 1.675513 1.395261 1.20086
miR-1287-5p 1.375363 1.590226 0.864885 11.45577 1.488279 7.697332
miR-193b-5p 1.131522 0.795113 1.423096 1.196795 0.446484 2.68049
miR-2116-3p 1.293168 0.650547 1.987817 1.077115 0.202947 5.307371
miR-2277-5p 1.810435 0.511144 3.541928 1.914872 0.398646 4.803438
miR-3158-3p 2.42469 1.135876 2.134644 2.094391 0.797292 2.62688
miR-3174 1.939752 2.385339 0.813198 3.291186 1.674314 1.965693
miR-3177-3p 2.15528 0.883459 2.439593 2.991987 0.744139 4.020735
miR-3651 2.263044 0.505981 4.472588 7.779167 0.811788 9.582753
miR-3691-5p 0.889053 0.795113 1.118147 1.271595 0.418578 3.037889
miR-378c 4.202797 0.397556 10.57157 1.196795 0.558105 2.144392
miR-3909 4.310561 1.060151 4.065989 1.396261 0.37207 3.752686
miR-4326 2.370808 2.385339 0.993908 2.792522 0.118501 23.56537
miR-500a-5p 3.23292 0.159023 20.32994 5.385577 0.446484 12.06221
miR-548l 1.375363 0.596335 2.30636 10.18291 0.279052 36.49105
miR-561-5p 2.586336 0.298167 8.674109 1.795192 0.279052 6.433177
miR-5690 1.939752 2.862407 0.677665 3.291186 0.892967 3.685674
miR-576-3p 3.556212 1.590226 2.236294 1.795192 1.395261 1.286635
miR-589-3p 2.047516 0.954136 2.145939 2.194124 0.37207 5.897079
miR-629-3p 5.50145 0.198778 27.67632 3.818591 0.139526 27.36829
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rmiR-651-5p 1.61646 0.463816 3.485133 
wo miRNAs eliminated are given in bold. FC, fold change.
A16 infection are still urgently needed and may  provide new
trategies for the development of more efﬁcacious vaccines to
revent HFMD outbreaks. In the current study, we identiﬁed a
otal of 154 known and 47 novel differentially expressed miRNAs
cross different time points following EV71 and CA16 infection,
ndicating that miRNA expression has strain- and time-speciﬁc
endencies in the context of these viruses. Cellular miRNAs, which
egulate over 60% of all human genes through the degradation of
arget mRNAs or the suppression of mRNA translation following
peciﬁc binding to target mRNA, affect a multitude of cellular
rocess, and their deregulation has been associated with the
evelopment and progression of various diseases (Treiber et al.,
012). Moreover, emerging evidence has shown that miRNAs
egulate cross-talk between host and pathogen in viral infections,2.991987 0.558105 5.36098
which is a major component of viral pathogenesis (Cullen, 2006;
Skalsky and Cullen, 2010). For example, hepatitis C virus (HCV)
notably increases cellular miRNA-122 expression, which in turn
activates viral genomic RNA replication, resulting in pathogenic
processes and regulating host anti-apoptotic gene expression
to enhance viral replication (Shan et al., 2007). Additionally, a
growing body of evidences have revealed that some small RNA
molecules were revealed to be involved in the infectious cycle
of CA16 or EV71 by different researchers, for example, elevated
expression of circulating miR876-5p is a speciﬁc response to
severe EV71 infections (Wang et al., 2016); EV71 could utilize
host miRNAs to enhance (e.g., miRNA-548 and miRNA-146a) or
suppress (e.g., miRNA-526a) its survival by directly or indirectly
targeting host molecules related to immune system processes
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Fig. 3. Signiﬁcantly enriched GO terms of biological process, molecular function and cellular component for the predicted targets. The DAVID web-based tool was  used to
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inalyze (a) biological process, (b) molecular function and (c) cellular component. GO
xis  plots the negative log of the adjusted P value (-log2P) and the vertical axis ex
olour  in this ﬁgure legend, the reader is referred to the web  version of this article.)
uring infection (Wu  et al., 2015); miR432* regulate the replication
f CA16 in RD cells (Yang and Tien, 2014b). Furthermore, other
tudies have veriﬁed that host miRNA expression signiﬁcantly
hanges in response to EV71 infection in Hep2 cells and RD
ells, which also implies that altered miRNA expression might
lay an essential role in EV71-host interactions (Cui et al., 2010;
ang and Tien, 2014a). Nonetheless, there are few studies on
ystematically comparing the common and differential aspects of
ellular miRNA alterations upon two enteroviral infections. Hence,
ur discovery of the speciﬁc miRNA expression patterns that are
roduced during EV71 and CA16 infection provides powerful
nsights into the different mechanisms of viral pathogenesis that
re regulated by miRNAs. Subsequently, to further elucidate the
ey disparities between EV71 and CA16 infection, we further
solated 56 differentially expressed miRNAs that displayed oppo-
ite expression trends. Preliminary reports of the functions of
hese 56 miRNAs have been made. For instance, miRNA-1246 was
iscovered as a target gene of p53 in the carcinogenic process
f various cancers, including cervical, colorectal, oesophageal,
epatic and pancreatic cancers (Kim et al., 2016). miRNA-3561
s closely related to tumour progression and clinical prognosis intional enrichment annotations exhibit in pie charts of the left panel. The horizontal
the GO category in bars of the right panel. (For interpretation of the references to
oesophageal squamous cell cancer (ESCC) and can therefore be
used as an independent prognostic biomarker for patients with
ESCC (Wang et al., 2015). miRNA–548 l is involved in the migration
and invasion of non-small cell lung cancer through its targeting
of the AKT1 signalling pathway (Liu et al., 2015). However, the
differential miRNA expression patterns in this study that follow
EV71 and CA16 infection remain largely unknown and need further
exploration. Recent studies have been reported that different miR-
NAs proﬁles of EV71 and CA16 infections were presented because
of different infected-cells or samples. For example, our previous
study on different miRNA proﬁles in rhesus monkey peripheral
blood mononuclear cells infected with EV71 and CA16 have
revealed that 20 (miR-96, let-7e-5p, miR-30a-3p, miR-582-5p,
miR-204-5p, miR-19b, miR-301b, miR-19a-3p, miR-301a-3p,
miR-182, miR-34c-5p, miR-200a-3p, miR-183-5p, miR-194-5p,
miR-193b-3p, miR-193a-3p, miR-196a-5p, miR-196b-5p,
miR-376a-3p, miR-146b-5p) known differentially expressed
miRNAs involved in immune system processes are the key miR-
NAs that underlie the different immune responses induced by
EV71 and CA16 infection (Hu et al., 2016). Cui et al. also found
that three key miRNAs (miR-545, miR-324-3p, and miR-143)
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Fig. 4. KEGG terms of the predicted targets of the differentially expressed miRNAs. (a) 123 KEGG pathway annotations for the miRNAs targets are exhibited in pie chart. The
red  fonts represented the differential pathways. (b) 3 differential pathways were displayed by a histogram with the −log2P value on the X-axis. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 5. Complexity of the miRNA-targets network, miRNA-GOs network, miRNA-pathways network and miRNA-TFs network after infection with EV71 and CA16. All red
circles  indicate upregulated miRNAs, while all dark blue circles indicate downregulated miRNAs in EV71 infection. Thus, these up-regulated and down-regulated miRNAs in
EV71  infection are decreased and increased in CA16 infection, respectively. Names of all miRNAs, targets, GOs, pathways and TFs are shown in ﬁgures. The size of nodes is
relative  to the importance of the miRNAs and other nodes. (a) miRNA-targets network. The targets are displayed by yellow color rounded rectangles. The thickness of the
edges  corresponds to the free energy of miRNA-mRNA duplex. (b) miRNA-GOs network. GO term nodes are depicted as green color rounded rectangles. Edges in the network
represent inhibitory effect of miRNAs on GOs. (c) miRNA-pathways network. Purple rectangle-shaped nodes denote pathways. Edges indicate a negative correlation between
miRNA and pathways. (d) miRNA-TFs network. Light blue rounded rectangles represent putative TFs. The grey lines width reﬂects the relative score. (For interpretation of
the  references to colour in this ﬁgure legend, the reader is referred to the web  version of this article.)
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odes,  from light to dark, displays the P value, from high to low (the lower the P value
f  the references to colour in this ﬁgure legend, the reader is referred to the web ve
an be used to distinguish EV71 infection from CA16 infection
n patients with HFMD and provide supplemental biomarkers
or diagnosing and subtyping enteroviral HFMD infections (Cui
t al., 2011). And Zhu et al. manifested that the expression levels
f 15 (miR-4508, miR-638, miR-762, miR-4466, miR-4787-5p,
iR-3196, miR-3960, miR-4516, miR-3656, miR-4668-5p, let-7b,
iR-320d, miR-151-5p, miR-4739, miR-320e) and 5(miR-26b,
iR-20b, miR-574-3p, miR-1280, miR-22) miRNAs were signiﬁ-
antly changed in CA16- and EV71-infected cells, respectively (Zhu
t al., 2016). Although the above mentioned miRNAs, as well as
he 56 miRNAs in current study, from different researchers were
ifferent, target gene prediction and subsequent bioinformatic
nalysis of these miRNAs could give a new clue to enhance our
nderstanding of the roles of miRNAs in HFMD pathogenesis.
To gain further insights into the miRNA-regulated mechanisms
hat occur during EV71 and CA16 infection, we  used GO and path-
ay analysis of the predicted target genes of the 56 differentially
xpressed miRNAs that were identiﬁed in trend analysis. Using
EGG pathway analysis and GO annotation for target genes can
ffer a better understanding of the target genes at the pathway,
olecular, cellular and biological levels. Our pathway enrichment
nalysis of the miRNA-predicted targets showed that the differen-
ially expressed miRNAs were involved in many immune-related
athways, such as apoptosis signalling pathway, B cell activation,
CKR signalling map, inﬂammation mediated by chemokine and
ytokine signalling pathway, interferon-gamma signalling path-
ay, interleukin signalling pathway, JAK-STAT signalling pathway,
-antigen biosynthesis, PI3 kinase pathway, Toll receptor signalling
athway, T cell activation and FAS signalling pathway. Further-
ore, biochemical and genetic studies have clariﬁed that miRNAs
ct as key regulators in the regulation of immune function, such
s antigen presentation (e.g., miR-155), T cell receptor signallingwas used to determine signiﬁcantly enriched GOs. The color gradient of the yellow
reater the GO signiﬁcance level). White nodes are no signiﬁcant. (For interpretation
of this article.)
(e.g., miR-181a), Toll-like receptor signalling and ensuing cytokine
responses (e.g., miR-146), etc (Sonkoly et al., 2008). Thus, we
hypothesized that miRNAs play a critical role in the regulation of
immune response during EV71 and CA16 infection in this work.
Additionally, the cellular component of GO analysis identiﬁed that
these genes are only enriched in actin cytoskeleton. Neverthe-
less, invasion of pathogens into host cells largely depends on actin
cytoskeleton rearrangement (Zhang et al., 2015). Hence, this result
indicated that miRNAs exert a possible regulatory mechanism on
genes associated with the actin cytoskeleton to inﬂuence viral inva-
sion. Next, the associations of the identiﬁed miRNAs with target
genes, GOs, pathways and TFs were further visualized by creating
regulatory networks.
Airway epithelial cells form a complex physical barrier through
tight cell-cell interactions and have a critical role in protecting
against invading pathogens and establishing mechanical strength
(Bals and Hiemstra, 2004; Brune et al., 2015). Once the integrity
of the airway epithelium is disrupted, viral pathogenesis is facili-
tated through increased viral invasion (Ganesan et al., 2013). Thus,
we mainly focused on the biological adhesion, cell adhesion and
cell-cell adhesion results derived from the GO analysis to perform
a more in-depth hierarchical GO category analysis. Among the 24
differentially expressed miRNAs related to biological adhesion, cell
adhesion and cell-cell adhesion, 17 exhibited a trend of consis-
tent expression, being predominantly down-regulated during EV71
infection and up-regulated during CA16 infection. Because of the
negative regulation that miRNAs exert on their target genes, it was
proposed that an inverse correlation existed between the miRNAs
and the corresponding GOs of their target genes. Notably, the func-
tions of biological adhesion, cell adhesion and cell-cell adhesion
induced by CA16 infection were signiﬁcantly inhibited, whereas
they were activated by EV71 infection. These results indicate that
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he biological adhesion, cell adhesion and cell-cell adhesion func-
ions that are induced by CA16 infection are more susceptible
o dysregulation than they are in the context of EV71 infection.
oreover, most of the target genes linked to biological adhesion,
ell adhesion and cell-cell adhesion for the above 17 differentially
xpressed miRNAs were overexpressed during EV71 infection but
educed during CA16 infection, as validated by qRT-PCR. There-
ore, it further demonstrated that epithelial cell-cell contacts could
e disturbed during CA16 infection, indicating epithelial barrier
mpairment. In addition, the cadherin signalling pathway and the
nt  signalling pathway, which exhibited signiﬁcant differences
uring EV71 and CA16 infection, are both highly related to epithe-
ial barrier function (Schlingmann et al., 2015; van Zuylen et al.,
016).Taken together, we could hypothesize that the repeatedly
ccurring phenomenon of CA16 infection in clinical features could
robably due to that CA16 infection easily caused destruction of
6HBE cells, which rarely happens following EV71 infection. With
egard to other distinct clinical symptoms following CA16 and
V71 infection might be related to airway epithelial cell immune
esponses, including cytokine and chemokine release, recruitment
f neutrophilic leucocytes and dendritic cells, and migration of
endritic cells to T-cell-enriched areas of draining regional lymph
odes, etc. Additionally, in our hierarchical GO category analysis, it
as also discovered that some GO terms involved in the nervous
ystem, such as neuron projection development, neuron projection
orphogenesis, axongenesis and nervous system development,
ight underlie the discrepant neuropathological manifestations
hat exist between EV17 and CA16 infection.
In summary, small RNA sequencing technology and bioinfor-
atics approaches were employed to identify miRNAs that are
ifferentially regulated in response to EV71 and CA16 infection
n 16HBE cells. The current study highlighted speciﬁc differential
xpression patterns of miRNAs during EV71 and CA16 infection,
lthough the exact functions of these miRNAs in viral pathogenesis
emain to be determined. GO and pathway analysis of the pre-
icted targets of the differentially expressed miRNAs screened from
rend analysis provided comprehensive information about the dis-
repant biological functions and pathways that are involved EV71
nd CA16 infection. Furthermore, the construction of detailed regu-
atory networks would greatly contribute to a better understanding
f the miRNA-mediated mechanisms that are involved in EV71 and
A16 infection. Consequently, it is worth noting that the 24 differ-
ntially expressed known miRNAs related to biological adhesion,
ell adhesion and cell-cell adhesion that were identiﬁed in this
tudy may  be the key miRNAs involved in modulating the func-
ion of the epithelial barrier. Furthermore, the 7 novel differentially
xpressed miRNAs screened from the trend analysis and not ana-
ysed in this study require further investigation and will provide
dditional insights into host-pathogen interactions and pathogen-
sis.
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